BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoffmann-vold A, Volkmann ER. Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches. Journal of Scleroderma and Related Disorders 2021;6:37-43. [DOI: 10.1177/2397198319891282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Shirai Y, Kawami N, Iwakiri K, Kuwana M. Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis. Journal of Scleroderma and Related Disorders 2022;7:57-61. [DOI: 10.1177/23971983211021747] [Cited by in F6Publishing: 1] [Reference Citation Analysis]